Overview
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
Eligibility
Inclusion Criteria:
- Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
- Subjects can be any gender but must be between (and including) the ages of 18 and 80.
- Subject ls being treated by the participating healthcare facility .
., Subject requires a trans-aortic valve replacement.
- Subject is able and willing to provide informed consent and HIPM authorization.
- Subject is able and willing to meet all study requirements.
Exclusion Criteria:
- Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
- Subject has a personal medical history that includes:
- Long O-T syndrome
- Cardiac channelopathies
- Seizures